1st September, 2021 4pm CET / 10am EST
What will this webinar address?
Over the past decade, outbreaks of H1N1 influenza, Sars-Cov, Ebola, and MERS have sparked ongoing conversations about strategic approaches and responses to pandemics and epidemics. With the spread of SARS-CoV-2 intensifying, scientists, together with pharmaceutical companies, are reinventing how to bring these life-saving drugs to market faster without impacting product quality, safety, or efficacy. The response has its own set of complex challenges that traditional manufacturing methods won’t solve.
This session will tackle some of the key lessons learned from the COVID 19 situation, the role, application, and potential of mRNA Vaccines technologies, as well as some of the challenges and considerations for achieving a robust global vaccine supply chain.
Discussion will cover:
- Lesson Learned from the global COVID 19 vaccine rollout
- Bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy
- Impacts and comparisons of classic platforms vs new-generation platforms
- Approaches to manage the unpredictable demand for life-saving product
- Need for reliable and robust manufacturing processes
- Selection of appropriate packaging components, raw materials, and procurement
- Ensuring robust supply chain and logistics
- Overview on the importance of fill/finish with a focus on m-RNA vaccine and how it fits in with the supply chain
- Learn how COVID-19 highlighted the necessity of a robust aseptic manufacturing capacity, some of the potential challenges, initial responses, and possible solutions
- Key global supply chain challenges for vaccine products
- Creating sustainable and resilient distribution systems.
Thought Leadership Director
Informa Pharma Intelligence
Daniel has a decade of experience as an analyst in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. He now develops and leads Informa Pharma Intelligence’s thought leadership program, producing materials that help clients across a range of hot topics in the biopharma industry, most recently including COVID-19, immuno-oncology, tumor-agnostic drug development, artificial intelligence and M&A. As part of this, Daniel regularly participates in webinars, conferences and other speaking arrangements, and he is featured across leading publications such as Nature Reviews Drug Discovery, Scientific American, Scrip, In Vivo and Vice. Prior to joining Informa, Daniel worked as a medicinal chemist at the UK biotech company Summit Therapeutics and graduated with First Class Honours in Natural Sciences from the University of Bath.
Vincenza Pironti PhD
Global SME, Steriles
Thermo Fisher Scientific
Vincenza Pironti supports the Global Sales and Business Development teams in providing technical support, designing strategies and supporting new business opportunities for Thermo Fisher’s sterile manufacturing business. Vincenza has more than 15 years of experience in the pharmaceutical industry with a consolidated experience on business development, product development, aseptic manufacturing and filling. She has extensive knowledge of all phases of product development from formulation screenings to sterile product commercial manufacturing with expertise in small and biologics in sterile formulation. Previously, Vincenza has worked as Business Development Manager in Pharmatex and CordenPharma managing multiple projects in sterile fields.
Global Commercial Director
Thermo Fisher Scientific
Scott Emery holds the position of Global Commercial Director of Total Transportation Management (TTM) at Thermo Fisher Scientific. Scott joined Thermo Fisher Scientific in 2013 and was responsible for their global transportation network including the management of offices located in the United States, United Kingdom, Switzerland & Singapore, prior to moving into his current role. Scott has 21 years of experience in global transportation and logistics. Previous to Thermo Fisher Scientific, Scott held leadership roles in global development, sales and operations at DHL Express & National Air Cargo.
This webinar is brought to you by
Title: mRNA vaccines, Trends, Technologies and Supply Chain
Date: 1st September, 2021
Time: 4pm CET / 10am EST
Duration: 60 minutes